Skip to content

Corona Serology Studies in IBD Patients (COSS!P)

Corona Serology Studies in IBD Patients (COSS!P) - COSS!P

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49552
Enrollment
2400
Registered
2020-05-27
Start date
2020-04-14
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IBD inflammatory bowel disease

Interventions

None listed

Sponsors

OLVG
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult (older than 18 y) patients with inflammatory bowel disease, under care in OLVG, undergoing blood sampling for routine care

Exclusion criteria

Exclusion criteria: Age below 18 years

Design outcomes

Primary

MeasureTime frame
Serological status for SARS-Covid 2 at regular intervals defined by the moments of routine blood sampling for the monitoring of disease activity and medication use

Secondary

MeasureTime frame
Short survey concerning symptoms that may be related to a SARS-Covid2 infection

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)